126 related articles for article (PubMed ID: 2369094)
1. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
Silvestru C; Socaciu C; Bara A; Haiduc I
Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
[TBL] [Abstract][Full Text] [Related]
2. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
3. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Organometallics. IV. The Mutagenic Potential of Some Diphenylantimony(III) Dithiophosphorus Derivatives.
Socaciu C; Pasca I; Silvestru C; Bara A; Haiduc I
Met Based Drugs; 1994; 1(4):291-7. PubMed ID: 18476242
[TBL] [Abstract][Full Text] [Related]
5. [Studies on antitumor effects of guanidino compounds and complexone derivatives (author's transl)].
Nagai T
Igaku Kenkyu; 1978 Jun; 48(5):333-467. PubMed ID: 102101
[No Abstract] [Full Text] [Related]
6. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
8. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
9. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents.
Ivanitskaya LP; Makukho LV
Neoplasma; 1975; 22(1):105-7. PubMed ID: 1153034
[TBL] [Abstract][Full Text] [Related]
10. [Ruthenium complexes as antitumor drugs: isolation of a new Ru (III) and iminodiacetic acid complex].
Vilaplana R; Basallote MG; González-Vilchez F
Rev Esp Oncol; 1984; 31(4):575-82. PubMed ID: 6571327
[TBL] [Abstract][Full Text] [Related]
11. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
13. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effects of rhodium metallo-organic compounds].
Giraldi T; Zassinovich G; Mestroni G
G Ital Chemioter; 1975; 22(1-2):1-4. PubMed ID: 1235341
[No Abstract] [Full Text] [Related]
15. Titanocene dichloride--the first metallocene with cancerostatic activity.
Köpf H; Köpf-Maier P
Angew Chem Int Ed Engl; 1979 Jun; 18(6):477-8. PubMed ID: 111586
[No Abstract] [Full Text] [Related]
16. Antitumor properties of selected 1,2,4-triazine derivatives.
Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
[TBL] [Abstract][Full Text] [Related]
17. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
Zhou JX; He GH; Tao LX; Xu B
Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
[No Abstract] [Full Text] [Related]
18. [Molybdocene dichloride as an antitumor agent (author's transl)].
Köpf-Maier P; Leitner M; Voigtländer R; Köpf H
Z Naturforsch C Biosci; 1979 Dec; 34(12):1174-6. PubMed ID: 161840
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of the development of Ehrlich ascites carcinoma by drugs interfering with histamine].
Bertolini A; Castelli M
G Ital Chemioter; 1975; 22(1-2):51-4. PubMed ID: 14864
[No Abstract] [Full Text] [Related]
20. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
Sava G; Zorzet S; Mestroni G; Zassinovich G
Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]